Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fractyl Health

1.37
+0.150012.30%
Volume:412.51K
Turnover:545.99K
Market Cap:67.02M
PE:-0.85
High:1.39
Open:1.23
Low:1.22
Close:1.22
Loading ...

After Plunging -19.55% in 4 Weeks, Here's Why the Trend Might Reverse for Fractyl Health, Inc. (GUTS)

Zacks
·
12 Feb

Bank of America Securities Keeps Their Buy Rating on Fractyl Health, Inc. (GUTS)

TIPRANKS
·
04 Feb

Fractyl Health, Inc. (GUTS) Receives a Buy from Morgan Stanley

TIPRANKS
·
03 Feb

Fractyl Health Inc: Streamlining Resources, Including Workforce Reduction Impacting 22 Employees, or About 17% of Workforce

THOMSON REUTERS
·
31 Jan

Fractyl Health Inc: in Connection With Strategic Reprioritization, Estimates That It Will Incur Cash Charges of About $1.8 Mln

THOMSON REUTERS
·
31 Jan

Fractyl Health Inc - Expects Cash Runway Extension Into 2026

THOMSON REUTERS
·
31 Jan

Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs With Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025

THOMSON REUTERS
·
31 Jan

Fractyl Health Inc - to Initiate First-in-Human Studies for Rjva-001 in H1 2025

THOMSON REUTERS
·
31 Jan

Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025

GlobeNewswire
·
31 Jan

Fractyl Health’s Promising Developments and Positive Outlook Justify Buy Rating

TIPRANKS
·
13 Jan

BRIEF-Fractyl Health Announces Positive Initial Clinical Results In First Patient Of The Reveal-1 Cohort

Reuters
·
13 Jan

Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following Glp-1 Discontinuation and Revita Procedure in First Patient of the Reveal-1 Cohort

THOMSON REUTERS
·
13 Jan

Fractyl Health Inc - First Study Patient Achieves 15% Weight Loss With Tirzepatide Over a Period of 7 Months

THOMSON REUTERS
·
13 Jan

Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort

GlobeNewswire
·
13 Jan

Here’s Why Fractyl Health, Inc. (NASDAQ:GUTS) Is Among the Best Diabetes Stocks to Buy Under $10

Insider Monkey
·
06 Jan

Fractyl Health to present new data on Rejuva Smart GLP-1 program

TIPRANKS
·
12 Dec 2024

Fractyl Health to Participate in the Upcoming December Conferences

GlobeNewswire
·
26 Nov 2024

Lee Ainslie's Strategic Reduction in Fractyl Health Inc Holdings

GuruFocus
·
15 Nov 2024

Fractyl Health Third Quarter 2024 Earnings: US$0.48 loss per share (vs US$9.61 loss in 3Q 2023)

Simply Wall St.
·
14 Nov 2024

Bank of America Securities Sticks to Their Buy Rating for Fractyl Health, Inc. (GUTS)

TIPRANKS
·
13 Nov 2024